instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'CANAKINUMAB'? | Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature.
Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome, and the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated myeloid-related proteinemia inflammatory (PAMI) sy... | Intravenous drip | DrugAdministrationRoute | CC BY | 34778321 | 20,486,510 | 2021 |
What was the outcome of reaction 'Kidney fibrosis'? | Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature.
Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome, and the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated myeloid-related proteinemia inflammatory (PAMI) sy... | Recovered | ReactionOutcome | CC BY | 34778321 | 20,529,869 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Pitt Hopkins-Like Syndrome 1 with Novel CNTNAP2 Mutation in Siblings.
Pitt Hopkins-like syndrome 1 (PTHLS1, OMIM # 610042) is an ultra-rare autosomal recessive condition with a prevalence of <1/1,000,000. Intragenic deletions of CNTNAP2 has been implicated in PTHLS1, however to our knowledge a compound heterozygous del... | LEVETIRACETAM, OXCARBAZEPINE | DrugsGivenReaction | CC BY-NC | 34778490 | 20,223,250 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sleep apnoea syndrome'. | Pitt Hopkins-Like Syndrome 1 with Novel CNTNAP2 Mutation in Siblings.
Pitt Hopkins-like syndrome 1 (PTHLS1, OMIM # 610042) is an ultra-rare autosomal recessive condition with a prevalence of <1/1,000,000. Intragenic deletions of CNTNAP2 has been implicated in PTHLS1, however to our knowledge a compound heterozygous del... | LEVETIRACETAM, OXCARBAZEPINE | DrugsGivenReaction | CC BY-NC | 34778490 | 20,223,250 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute macular neuroretinopathy'. | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | ETHINYL ESTRADIOL\NORGESTIMATE, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercoagulation'. | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | ETHINYL ESTRADIOL\NORGESTIMATE, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual field defect'. | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | ETHINYL ESTRADIOL\NORGESTIMATE, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
What was the administration route of drug 'ETHINYL ESTRADIOL\NORGESTIMATE'? | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
What was the dosage of drug 'ETHINYL ESTRADIOL\NORGESTIMATE'? | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | UNK (0.25MG/ 35MCG) | DrugDosageText | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
What was the outcome of reaction 'Hypercoagulation'? | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | Recovering | ReactionOutcome | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
What was the outcome of reaction 'Visual field defect'? | Acute macular neuroretinopathy associated with COVID-19 infection.
To report a case of bilateral acute macular neuroretinopathy (AMN) associated with a COVID-19 infection.
A 22-year-old female was referred for evaluation of bilateral scotomas concurrent with a mildly symptomatic COVID-19 infection. Exam showed normal v... | Recovering | ReactionOutcome | CC BY-NC-ND | 34778601 | 20,228,986 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Action tremor'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ataxia'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Balance disorder'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bipolar disorder'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disorientation'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysarthria'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysdiadochokinesis'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysstasia'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Essential tremor'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait disturbance'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intellectual disability'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intention tremor'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Memory impairment'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Postictal state'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,154,783 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Postural tremor'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Schizophrenia'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Action tremor'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Ataxia'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Balance disorder'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Bipolar disorder'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Decreased appetite'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Disorientation'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Dysarthria'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Dysdiadochokinesis'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Dysstasia'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
What was the outcome of reaction 'Essential tremor'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
What was the outcome of reaction 'Gait disturbance'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
What was the outcome of reaction 'Intellectual disability'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Intention tremor'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Memory impairment'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Neurotoxicity'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,154,318 | 2021-11-15 |
What was the outcome of reaction 'Postictal state'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,154,783 | 2021-11-15 |
What was the outcome of reaction 'Postural tremor'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Schizophrenia'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Somnolence'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Status epilepticus'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
What was the outcome of reaction 'Weight decreased'? | Tacrolimus-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report.
BACKGROUND
Tacrolimus is a macrolide immunosuppressant widely used to prevent rejection after solid organ transplantation. In general, adverse events of tacrolimus occur more often as the conce... | Recovered | ReactionOutcome | CC BY | 34781882 | 20,133,674 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,949,540 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Empyema'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,949,540 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fusobacterium infection'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISOLONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,890,207 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial effusion'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,949,540 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISOLONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,890,207 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleurisy'. | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | CEFTRIAXONE, DOXYCYCLINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PREDNISOLONE, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC-ND | 34782592 | 20,890,207 | 2021-11-16 |
What was the outcome of reaction 'Bacterial pericarditis'? | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34782592 | 20,938,518 | 2021-11-16 |
What was the outcome of reaction 'Empyema'? | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34782592 | 20,949,540 | 2021-11-16 |
What was the outcome of reaction 'Pericardial effusion'? | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34782592 | 20,949,540 | 2021-11-16 |
What was the outcome of reaction 'Pleural effusion'? | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34782592 | 20,890,207 | 2021-11-16 |
What was the outcome of reaction 'Pleurisy'? | Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report.
BACKGROUND Bacterial pericarditis can present a diagnostic challenge due to the difficulty of obtaining tissue for bacterial identification. This report is of a 34-year-old man who presented with fever and cough. Diagnosis ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34782592 | 20,890,207 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
High-dose methylprednisolone plus rituximab (R-HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo-immunotherapy and has p... | METHYLPREDNISOLONE SODIUM SUCCINATE, RITUXIMAB, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34783174 | 20,135,056 | 2021-11-16 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
High-dose methylprednisolone plus rituximab (R-HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo-immunotherapy and has p... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34783174 | 20,135,056 | 2021-11-16 |
What was the administration route of drug 'RITUXIMAB'? | Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
High-dose methylprednisolone plus rituximab (R-HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo-immunotherapy and has p... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34783174 | 20,135,056 | 2021-11-16 |
What was the outcome of reaction 'Infection'? | Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited.
High-dose methylprednisolone plus rituximab (R-HDMP) is a useful treatment in chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) patients unfit for chemo-immunotherapy and has p... | Fatal | ReactionOutcome | CC BY | 34783174 | 20,135,056 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | DESLANOSIDE, METOPROLOL SUCCINATE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | DESLANOSIDE, METOPROLOL SUCCINATE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | DESLANOSIDE, METOPROLOL SUCCINATE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular pre-excitation'. | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | DESLANOSIDE, METOPROLOL SUCCINATE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
What was the outcome of reaction 'Tachycardia'? | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | Recovered | ReactionOutcome | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
What was the outcome of reaction 'Ventricular pre-excitation'? | Atrioventricular accessory pathway unmasked by heart valve replacement.
A 50-year-old male patient with a history of severe valvular regurgitation underwent mitral and aortic valve replacement surgery 3 months ago. Preoperative 12-lead electrocardiogram presented atrial flutter (AFL) and atrial fibrillation. AFL compli... | Recovered | ReactionOutcome | CC BY | 34783420 | 20,938,928 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone giant cell tumour'. | Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.
BACKGROUND
Extended curettage has increasingly become the preferred treatment for giant cell tumour of bone (GCTB), but the high recurrence rate after curettage poses a major challenge for or... | DENOSUMAB | DrugsGivenReaction | CC BY | 34783889 | 20,819,484 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | LABETALOL\LABETALOL HYDROCHLORIDE, LEVETIRACETAM, MAGNESIUM SULFATE, NIMODIPINE, PROPOFOL | DrugsGivenReaction | CC BY-NC-ND | 34784343 | 20,339,153 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | LABETALOL\LABETALOL HYDROCHLORIDE, LEVETIRACETAM, MAGNESIUM SULFATE, MILRINONE, NICARDIPINE, NIMODIPINE, PROPOFOL | DrugsGivenReaction | CC BY-NC-ND | 34784343 | 20,131,901 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia staphylococcal'. | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | LABETALOL\LABETALOL HYDROCHLORIDE, LEVETIRACETAM, MAGNESIUM SULFATE, MILRINONE, NICARDIPINE, NIMODIPINE, PROPOFOL | DrugsGivenReaction | CC BY-NC-ND | 34784343 | 20,131,901 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Reversible cerebral vasoconstriction syndrome'. | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | LABETALOL\LABETALOL HYDROCHLORIDE, LEVETIRACETAM, MAGNESIUM SULFATE, MILRINONE, NICARDIPINE, NIMODIPINE, PROPOFOL | DrugsGivenReaction | CC BY-NC-ND | 34784343 | 20,131,901 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tracheostomy'. | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | LABETALOL\LABETALOL HYDROCHLORIDE, LEVETIRACETAM, MAGNESIUM SULFATE, MILRINONE, NICARDIPINE, NIMODIPINE, PROPOFOL | DrugsGivenReaction | CC BY-NC-ND | 34784343 | 20,131,901 | 2021-11-16 |
What was the administration route of drug 'MILRINONE'? | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
BACKGROUND Reversible cerebral vasoconstriction syndrome (RCVS) is a rare neurological disorder with a complex physiopathology that is not fully understood. Suggested underlying mechanisms include failure of aut... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34784343 | 20,131,901 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
Rationale: The cystic fibrosis (CF) modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) proved highly effective in controlled clinical trials for individuals with ≥1 F508del allele, which occurs in at least 85% of people with CF... | ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | DrugsGivenReaction | CC BY-NC-ND | 34784492 | 20,484,515 | 2021-11-16 |
What was the administration route of drug 'ELEXACAFTOR\IVACAFTOR\TEZACAFTOR'? | Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
Rationale: The cystic fibrosis (CF) modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) proved highly effective in controlled clinical trials for individuals with ≥1 F508del allele, which occurs in at least 85% of people with CF... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34784492 | 20,484,515 | 2021-11-16 |
What was the outcome of reaction 'Death'? | Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.
Rationale: The cystic fibrosis (CF) modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) proved highly effective in controlled clinical trials for individuals with ≥1 F508del allele, which occurs in at least 85% of people with CF... | Fatal | ReactionOutcome | CC BY-NC-ND | 34784492 | 20,484,515 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholestasis'. | In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report.
BACKGROUND
Citomegalovirus (CMV) infects approximately 1% of live newborns. About 10% of the infants affected by congenital CMV infection are symptomatic at birth and up to 60% of these in... | GANCICLOVIR, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 34784934 | 20,213,278 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report.
BACKGROUND
Citomegalovirus (CMV) infects approximately 1% of live newborns. About 10% of the infants affected by congenital CMV infection are symptomatic at birth and up to 60% of these in... | GANCICLOVIR, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 34784934 | 20,213,278 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report.
BACKGROUND
Citomegalovirus (CMV) infects approximately 1% of live newborns. About 10% of the infants affected by congenital CMV infection are symptomatic at birth and up to 60% of these in... | GANCICLOVIR, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 34784934 | 20,235,440 | 2021-11-16 |
What was the administration route of drug 'GANCICLOVIR'? | In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report.
BACKGROUND
Citomegalovirus (CMV) infects approximately 1% of live newborns. About 10% of the infants affected by congenital CMV infection are symptomatic at birth and up to 60% of these in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34784934 | 20,235,440 | 2021-11-16 |
What was the administration route of drug 'VALGANCICLOVIR'? | In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report.
BACKGROUND
Citomegalovirus (CMV) infects approximately 1% of live newborns. About 10% of the infants affected by congenital CMV infection are symptomatic at birth and up to 60% of these in... | Oral | DrugAdministrationRoute | CC BY | 34784934 | 20,235,440 | 2021-11-16 |
What was the administration route of drug 'METHOTREXATE SODIUM'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Oral | DrugAdministrationRoute | CC BY | 34784967 | 20,532,909 | 2021-11-16 |
What was the administration route of drug 'METHOTREXATE'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Oral | DrugAdministrationRoute | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
What was the outcome of reaction 'Abdominal lymphadenopathy'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Not recovered | ReactionOutcome | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
What was the outcome of reaction 'Hilar lymphadenopathy'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Not recovered | ReactionOutcome | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
What was the outcome of reaction 'Leukoencephalopathy'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Not recovered | ReactionOutcome | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
What was the outcome of reaction 'Pneumonia aspiration'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Fatal | ReactionOutcome | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
What was the outcome of reaction 'Urinary incontinence'? | Uncertainty of leukoencephalopathies: a case report.
BACKGROUND
Adult-onset leukoencephalopathies are a group of heterogeneous disorders characterized by white matter abnormalities. Leukoencephalopathy is usually encountered in children, but here we report a case with adult-onset leukoencephalopathy. Also, we explore t... | Not recovered | ReactionOutcome | CC BY | 34784967 | 20,525,027 | 2021-11-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who receive... | BLINATUMOMAB, CYCLOSPORINE, ETOPOSIDE, RITUXIMAB, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 34786202 | 20,305,889 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who receive... | BLINATUMOMAB, CYCLOSPORINE, ETOPOSIDE, RITUXIMAB, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 34786202 | 20,305,889 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral load increased'. | Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who receive... | BLINATUMOMAB, CYCLOSPORINE, ETOPOSIDE, RITUXIMAB, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 34786202 | 20,305,889 | 2021-12 |
What was the dosage of drug 'RITUXIMAB'? | Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.
Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who receive... | FOUR WEEKLY DOSES | DrugDosageText | CC BY | 34786202 | 20,305,889 | 2021-12 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.